VISCHER acted as Swiss counsel to Santis Pharma in collaboration with lead counsel Archers Avocats. Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements...
Santis Pharma’s Investment Round From Abenex
Constructor Group’s Corporate Reorganization in Switzerland
VISCHER advised Constructor Group on the operation. Through its for-profit and nonprofit entities that combine notably a university, a research center, businesses, consulting services, incubation, and...
Helsinn’s Financing Agreement with Oberland Capital
VISCHER advised Oberland Capital in this transaction. Oberland Capital Management LLC signed a financing agreement with the Helsinn Group. Oberland Capital is a private investment firm...
E3 Holding AG’s Acquisition of Clean-tek Gruppe
VISCHER acted as lead counsel to the buyer. Heuking Kühn Lüer Wojtek advised NORD/LB Norddeutsche Landesbank – Girozentrale. E3 Holding AG, Germany, has acquired the clean-tek...
Invision’s CHF 145 Million Continuation Fund Closing
Niederer Kraft Frey and Vischer advised Invision on the deal. Invision, a leading investment group, announced the launch and successful closing of Invision Logistics LP, a...
Dermavant Sciences’ $200 Million Financing
VISCHER acted as Swiss counsel to Dermavant in the transaction. Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, entered...